Catapres-TTS-3 .3 mg/d
clonidine transdermal system · PATCH · Technomed Inc.
Catapres-TTS-3 is a patch containing clonidine transdermal system at .3 mg/d, taken transdermal. Manufactured by Technomed Inc..
Key Facts
- Brand Name
- Catapres-TTS-3
- Generic Name
- clonidine transdermal system
- NDC Code (Product)
82089-203- Manufacturer
- Technomed Inc.
- Strength
- .3 mg/d
- Dosage Form
- PATCH
- Route
- TRANSDERMAL
- Marketing Status
- Application #
- NDA018891
- Drug Class
- Central alpha-2 Adrenergic Agonist [EPC]
- Marketing Start
- 03/30/2026
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Catapres-TTS-3 used for?
Catapres-TTS-3 contains clonidine transdermal system. It is a patch taken transdermal. Consult your doctor for specific uses.
Is Catapres-TTS-3 a controlled substance?
Catapres-TTS-3 is not classified as a controlled substance by the DEA.
What is the generic name for Catapres-TTS-3?
The generic name for Catapres-TTS-3 is clonidine transdermal system. There are 10 other brand versions of clonidine transdermal system.
What is the NDC code for Catapres-TTS-3 .3 mg/d?
The NDC (National Drug Code) for Catapres-TTS-3 .3 mg/d is 82089-203, listed by Technomed Inc..
Other Catapres-TTS-3 Dosages
Other Clonidine Brands
See all →- Clonidine Transdermal System USP, 0.2 mg/day.2 mg/d52817-611
- Clonidine Transdermal System USP, 0.3 mg/day.3 mg/d52817-612
- Catapres-TTS-2.2 mg/d82089-102
- Clonidine Transdermal System USP, 0.1 mg/day.1 mg/d52817-505
- Clonidine Transdermal System USP, 0.3 mg/day.3 mg/d52817-507
- Catapres-TTS-2.2 mg/d82089-202
- Catapres-TTS-1.1 mg/d82089-101
- Catapres-TTS-1.1 mg/d82089-201
- Clonidine Transdermal System USP, 0.2 mg/day.2 mg/d52817-506
- Clonidine Transdermal System USP, 0.1 mg/day.1 mg/d52817-610
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)